PRESS RELEASE published on 02/28/2023 at 13:30, 3 years 1 month ago Moderna to Present at Cowen's 43rd Annual Health Care Conference
PRESS RELEASE published on 02/23/2023 at 13:00, 3 years 1 month ago Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates
PRESS RELEASE published on 02/22/2023 at 22:05, 3 years 1 month ago Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Mela
PRESS RELEASE published on 02/22/2023 at 13:00, 3 years 1 month ago Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
PRESS RELEASE published on 02/17/2023 at 17:00, 3 years 1 month ago Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
PRESS RELEASE published on 02/16/2023 at 22:05, 3 years 1 month ago Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
PRESS RELEASE published on 02/02/2023 at 13:00, 3 years 2 months ago Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
PRESS RELEASE published on 01/30/2023 at 13:15, 3 years 2 months ago Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
PRESS RELEASE published on 01/17/2023 at 22:05, 3 years 2 months ago Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults
PRESS RELEASE published on 01/09/2023 at 13:00, 3 years 2 months ago Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
Published on 04/02/2026 at 22:00, 18 hours 29 minutes ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 21 hours 57 minutes ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 1 hour ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 1 hour ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 1 hour ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/03/2026 at 16:05, 23 minutes ago From CES to Market: GOALKER Launches Unicut Series Online as H3 Pro Hits Kickstarter
Published on 04/03/2026 at 14:40, 1 hour 48 minutes ago Monport Launches Next-Generation UV Laser Engraver for Precision Marking Across Europe
Published on 04/03/2026 at 14:35, 1 hour 53 minutes ago Monport Expands Laser Technology Portfolio with Mega S CO2 Laser and UV Laser Engravers
Published on 04/03/2026 at 14:05, 2 hours 23 minutes ago AIRSEEKERS Tron and Tron SE Series Now Available: Redefining "Real Mowing" with FlowCut™ Technology
Published on 04/03/2026 at 11:05, 5 hours 23 minutes ago Hoymiles Bolsters European Plug-in Solar & Storage Market with HiFlow & HiFlow Pro Microinverters
Published on 04/03/2026 at 13:29, 2 hours 59 minutes ago Total number of voting rights and shares making up the share capital at March 31, 2026
Published on 04/03/2026 at 12:57, 3 hours 31 minutes ago Mersen: Number of shares and voting rights as of March 31, 2026
Published on 04/02/2026 at 18:30, 21 hours 59 minutes ago Thales makes available its Universal Registration Document 2025
